샘플 요청 목록

 카트 문의
시장보고서
상품코드
1908595

흉부 카테터 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 제품별, 최종 용도별, 용도별, 지역별, 부문별 예측(2026-2033년)

Thoracic Catheters Market Size, Share & Trends Analysis Report By Material, By Product, By End-use, By Application, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

흉부 카테터 시장 개요

세계의 흉부 카테터 시장 규모는 2025년에 4억 8,443만 달러로 추정되며, 2033년에 7억 4,891만 달러에 달할 것으로 예측됩니다.

2026년부터 2033년까지 CAGR 5.69%로 성장할 것으로 예상됩니다. 최소침습적 미용 시술에 대한 수요 증가, 나이를 초월한 아름다움에 대한 관심 증가, 젊은 층의 외모에 대한 인식 향상 등이 시장 성장을 이끄는 주요 요인으로 꼽히고 있습니다.

최소침습 수술과 로봇 보조 수술을 포함한 흉부 및 폐 수술이 증가함에 따라, 효율적인 체액 배출과 환자 회복을 촉진하는 첨단 카테터 시스템에 대한 수요가 증가하고 있습니다. 영국 보건안전청과 기후건강안전센터가 2025년 8월에 발표한 자료에 따르면, 영국에서 천식이 널리 퍼져 있으며, 720만 명이 이 질병을 앓고 있습니다.

흉수, 기흉, 폐암, 만성폐쇄성폐질환(COPD), 수술 후 합병증 등 호흡기 및 흉부 질환의 증가는 흉부 카테터 산업을 견인하는 주요 요인입니다. 이러한 질환은 종종 흉강 내 공기와 체액 저류를 유발하여 배액 및 호흡 보조용 흉부 카테터를 사용해야 합니다. 전 세계 흡연율 증가, 대기오염, 생활습관 관련 폐질환의 증가도 흉부 카테터 치료 건수 증가에 기여하고 있습니다. 더 많은 환자들이 흉막 관리를 위한 효과적이고 최소침습적인 치료법을 필요로 하는 가운데, 안전성, 편안함, 감염 관리가 개선된 첨단 카테터에 대한 수요는 지속적으로 증가하고 있습니다. 이러한 추세는 특히 복잡한 흉부 및 폐 질환을 자주 다루는 병원과 중환자실에서 시장의 견조한 성장을 지속할 것으로 예상됩니다.

자주 묻는 질문

  • 흉부 카테터 시장 규모는 어떻게 예측되나요?
  • 흉부 카테터 시장 성장을 이끄는 주요 요인은 무엇인가요?
  • 흉부 카테터에 대한 수요가 증가하는 이유는 무엇인가요?
  • 호흡기 및 흉부 질환의 증가는 흉부 카테터 산업에 어떤 영향을 미치나요?
  • 흉부 카테터 시장의 주요 기업은 어디인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 흉부 카테터 시장 변수, 동향과 범위

  • 시장 계통 전망
    • 상부 시장 전망
    • 관련·보조 시장 전망
  • 시장 역학
  • 흉부 카테터 시장 분석 툴
    • 산업 분석 - Porter's Five Forces 분석
    • PESTEL 분석

제4장 흉부 카테터 시장 : 재료별, 추정·동향 분석

  • 흉부 카테터 시장 : 재료 대시보드
  • 흉부 카테터 시장 : 재료 변동 분석
  • 흉부 카테터 시장 규모 및 예측과 동향 분석(재료별, 2021-2033년)
    • PVC
    • 실리콘
    • 폴리우레탄
    • 기타

제5장 흉부 카테터 시장 : 제품별, 추정·동향 분석

  • 흉부 카테터 시장 : 제품 대시보드
  • 흉부 카테터 시장 : 제품 변동 분석
  • 흉강 카테터 시장 규모 및 예측과 동향 분석(제품별, 2021-2033년)
    • 흉강 배액 튜브
    • 흉강 배액 카테터
    • 기타

제6장 흉부 카테터 시장 : 용도별, 추정·동향 분석

  • 흉부 카테터 시장 : 용도 대시보드
  • 흉부 카테터 시장 : 용도 변동 분석
  • 흉강 카테터 시장 규모 및 예측과 동향 분석(용도별, 2021-2033년)
    • 기흉
    • 흉수
    • 혈흉
    • 기타

제7장 흉부 카테터 시장 : 최종 용도별, 추정·동향 분석

  • 흉부 카테터 시장 : 최종 용도 대시보드
  • 흉부 카테터 시장 : 최종 용도 변동 분석
  • 흉강 카테터 시장 규모 및 예측과 동향 분석(최종 용도별, 2021-2033년)
    • 병원
    • 전문 클리닉
    • 외래 수술 센터(ASC)
    • 기타

제8장 흉부 카테터 시장 : 지역별, 추정·동향 분석(재료, 제품, 용도, 최종 용도, 지역별)

  • 세계의 흉부 카테터 시장 : 지역별 대시보드
  • 시장 규모와 예측, 동향 분석(2021-2033년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 스웨덴
    • 노르웨이
    • 덴마크
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 사우디아라비아
    • 남아프리카공화국
    • 아랍에미리트
    • 쿠웨이트

제9장 경쟁 구도

  • 주요 시장 진입 기업의 최근 동향과 영향 분석
  • 기업/경쟁 분류
    • 이노베이터
  • 벤더 상황
    • 주요 유통업체와 채널 파트너 리스트
    • 주요 기업의 시장 점유율 분석, 2025년
    • Teleflex Incorporated
    • Smiths Medical(ICU Medical, Inc.)
    • B. Braun Melsungen AG
    • Vygon SA
    • Cook Medical
    • Terumo Corporation
    • Nipro Corporation
    • Asahi Kasei Corporation
    • Becton, Dickinson and Company
    • Dongguan Jiajie Medical Tech Co., Ltd.
KSM 26.01.27

Thoracic Catheters Market Summary

The global thoracic catheters market size was estimated at USD 484.43 million in 2025 and is projected to reach USD 748.91 million by 2033, growing at a CAGR of 5.69% from 2026 to 2033. The rising demand for minimally invasive aesthetic procedures, the growing trend of ageless beauty, and increasing awareness among the young population about physical appearance are some of the major factors driving the growth of the market.

The increasing number of thoracic and pulmonary surgeries, including minimally invasive and robotic-assisted procedures, has driven up the demand for advanced catheter systems to ensure efficient fluid evacuation and promote patient recovery. According to data published by the UK Health Security Agency and the Centre for Climate and Health Security in August 2025, asthma is prevalent in the UK, with 7.2 million people suffering from the condition.

The increasing prevalence of respiratory and thoracic conditions such as pleural effusion, pneumothorax, lung cancer, chronic obstructive pulmonary disease, and post-surgical complications is a primary factor driving the thoracic catheter industry. These conditions often lead to the accumulation of air or fluid in the pleural cavity, necessitating the use of thoracic catheters for drainage and respiratory support. The global rise in smoking rates, air pollution, and lifestyle-related lung disorders has further contributed to the growing number of thoracic interventions. As more patients require effective and minimally invasive solutions for pleural management, the demand for advanced catheters with improved safety, comfort, and infection control continues to increase. This trend is expected to sustain strong market growth, particularly in hospitals and critical care units that frequently manage complex thoracic and pulmonary cases.

Global Thoracic Catheters Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global thoracic catheters market report based on the material, product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Thoracostomy Tubes
  • Pleural Drainage Catheters
  • Others
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Silicone
  • Polyurethane
  • PVC
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Pneumothorax
  • Pleural Effusion
  • Hemothorax
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Material
    • 1.1.2. Product
    • 1.1.3. Application
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity price analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Material outlook
    • 2.2.2. Type outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Thoracic Catheters Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of respiratory and thoracic conditions
      • 3.2.1.2. Increasing number of thoracic surgeries and minimally invasive procedures
      • 3.2.1.3. Technological innovation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of complications and infections
      • 3.2.2.2. High cost of advanced devices
    • 3.2.3. Market Challenge Analysis
      • 3.2.3.1. Availability of alternative treatments
      • 3.2.3.2. Regulatory and compliance barriers
    • 3.2.4. Market Opportunity Analysis
      • 3.2.4.1. Rising demand for minimally invasive procedures
      • 3.2.4.2. Expanding healthcare infrastructure in emerging markets
  • 3.3. Thoracic Catheters Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Thoracic Catheters Market: Material Estimates & Trend Analysis

  • 4.1. Thoracic Catheters Market: Material Dashboard
  • 4.2. Thoracic Catheters Market: Material Movement Analysis
  • 4.3. Thoracic Catheters Market Size & Forecasts and Trend Analysis, by Material, 2021 to 2033 (USD Million)
    • 4.3.1. PVC
      • 4.3.1.1. PVC market estimates and forecast 2021 to 2033, (USD Million)
    • 4.3.2. Silicone
      • 4.3.2.1. Silicone market estimates and forecast 2021 to 2033s, (USD Million)
    • 4.3.3. Polyurethane
      • 4.3.3.1. Polyurethane market estimates and forecast 2021 to 2033s, (USD Million)
    • 4.3.4. Others
      • 4.3.4.1. Others market estimates and forecast 2021 to 2033s, (USD Million)

Chapter 5. Thoracic Catheters Market: Product Estimates & Trend Analysis

  • 5.1. Thoracic Catheters Market: Product Dashboard
  • 5.2. Thoracic Catheters Market: Product Movement Analysis
  • 5.3. Thoracic Catheters Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
    • 5.3.1. Thoracostomy Tubes
      • 5.3.1.1. Thoracostomy tubes market estimates and forecast 2021 to 2033, (USD Million)
    • 5.3.2. Pleural Drainage Catheters
      • 5.3.2.1. Pleural drainage catheters market estimates and forecast 2021 to 2033, (USD Million)
    • 5.3.3. Others
      • 5.3.3.1. Others market estimates and forecast 2021 to 2033, (USD Million)

Chapter 6. Thoracic Catheters Market: Application Estimates & Trend Analysis

  • 6.1. Thoracic Catheters Market: Application Dashboard
  • 6.2. Thoracic Catheters Market: Application Movement Analysis
  • 6.3. Thoracic Catheters Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 6.3.1. Pneumothorax
      • 6.3.1.1. Pneumothorax market estimates and forecast 2021 to 2033, (USD Million)
    • 6.3.2. Pleural Effusion
      • 6.3.2.1. Pleural effusion market estimates and forecast 2021 to 2033, (USD Million)
    • 6.3.3. Hemothorax
      • 6.3.3.1. Hemothorax market estimates and forecast 2021 to 2033, (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Others market estimates and forecast 2021 to 2033, (USD Million)

Chapter 7. Thoracic Catheters Market: End Use Estimates & Trend Analysis

  • 7.1. Thoracic Catheters Market: End Use Dashboard
  • 7.2. Thoracic Catheters Market: End Use Movement Analysis
  • 7.3. Thoracic Catheters Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Hospitals
      • 7.3.1.1. Hospitals market estimates and forecast 2021 to 2033, (USD Million)
    • 7.3.2. Specialty Clinics
      • 7.3.2.1. Specialty clinics market estimates and forecast 2021 to 2033, (USD Million)
    • 7.3.3. Ambulatory Surgical Centers (ASCs)
      • 7.3.3.1. Ambulatory Surgical Centers (ASCs) market estimates and forecast 2021 to 2033, (USD Million)
    • 7.3.4. Others
      • 7.3.4.1. Others market estimates and forecast 2021 to 2033, (USD Million)

Chapter 8. Thoracic Catheters Market: Regional Estimates & Trend Analysis by Material, Product, Application, End Use, and Region

  • 8.1. Global Thoracic Catheters Market: Regional Dashboard
  • 8.2. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement scenario
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement scenario
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Canada market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Regulatory framework/ reimbursement scenario
      • 8.3.4.3. Competitive scenario
      • 8.3.4.4. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement scenario
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. UK market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement scenario
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Germany market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement scenario
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. France market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement scenario
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Italy market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement scenario
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Spain market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement scenario
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.4.8. Norway
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement scenario
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Norway market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.4.9. Denmark
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement scenario
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement scenario
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement scenario
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Japan market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement scenario
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. India market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement scenario
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Australia market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement scenario
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement scenario
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement scenario
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement scenario
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement scenario
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.7.3. South Africa
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement scenario
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement scenario
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. UAE market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement scenario
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key company market share analysis, 2025
    • 9.3.3. Teleflex Incorporated
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Smiths Medical (ICU Medical, Inc.)
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. B. Braun Melsungen AG
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Vygon SA
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Cook Medical
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Terumo Corporation
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Nipro Corporation
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Asahi Kasei Corporation
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Becton, Dickinson and Company
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Dongguan Jiajie Medical Tech Co., Ltd.
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제